FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2108683345> ?p ?o ?g. }

• W2108683345 endingPage "369" @default.
• W2108683345 startingPage "362" @default.
• W2108683345 abstract "ABSTRACT Obesity is associated with blunted GH secretion, unfavorable body composition, and increased cardiovascular mortality. The objective of this study was to investigate the effects of oral treatment with the GH secretagogue MK-677 on GH secretion and body composition in otherwise healthy obese males. The study was randomized, double blind, parallel, and placebo controlled. Twenty-four obese males, aged 18–50 yr, with body mass indexes greater than 30 kg/m2 and waist/hip ratios greater than 0.95, were treated with MK-677 25 mg (n = 12) or placebo (n = 12) daily for 8 weeks. Serum insulin-like growth factor I (IGF-I) increased approximately 40% with MK-677 treatment (P < 0.001 vs. placebo). Serum IGF-binding protein-3 was also significantly increased (P ≤ 0.001 vs. placebo). GH and PRL (peak and area under the curve values) were significantly increased after the initial dose of MK-677. Significant increases, with the exception of peak PRL, persisted at 2 and 8 weeks of treatment. The increases in GH and PRL after the initial dose were significantly greater than the increase seen after multiple doses. Serum and urinary concentrations of cortisol were not increased at 2 and 8 weeks (P = NS, vs. placebo). Fat-free mass increased significantly in the MK-677 treatment group when determined with dual energy x-ray absorptiometry (P < 0.01) or using a four-compartment model (P < 0.05). Total and visceral fat were not significantly changed with active therapy. The basal metabolic rate was significantly increased at 2 weeks of MK-677 treatment (P = 0.01) but not at 8 weeks (P = 0.1). Fasting concentrations of glucose and insulin were unchanged, whereas an oral glucose tolerance test showed impairment of glucose homeostasis at 2 and 8 weeks. We conclude that 2-month treatment with MK-677 in healthy obese males caused a sustained increase in serum levels of GH, IGF-I, and IGF-binding protein-3. The effects on cortisol secretion were transient. Changes in body composition and energy expenditure were of an anabolic nature, with a sustained increase in fat-free mass and a transient increase in basal metabolic rate. Further studies are needed to evaluate whether a higher dose of MK-677 or a more prolonged treatment period can promote a reduction in body fat." @default.
• W2108683345 created "2016-06-24" @default.
• W2108683345 creator A5019588231 @default.
• W2108683345 creator A5020828922 @default.
• W2108683345 creator A5021824564 @default.
• W2108683345 creator A5035917425 @default.
• W2108683345 creator A5036225117 @default.
• W2108683345 creator A5054386349 @default.
• W2108683345 creator A5057810981 @default.
• W2108683345 creator A5063690905 @default.
• W2108683345 creator A5064098247 @default.
• W2108683345 creator A5068392916 @default.
• W2108683345 creator A5081672652 @default.
• W2108683345 creator A5085391346 @default.
• W2108683345 date "1998-02-01" @default.
• W2108683345 modified "2023-10-05" @default.
• W2108683345 title "Two-Month Treatment of Obese Subjects with the Oral Growth Hormone (GH) Secretagogue MK-677 Increases GH Secretion, Fat-Free Mass, and Energy Expenditure1" @default.
• W2108683345 cites W1803153610 @default.
• W2108683345 cites W1933010092 @default.
• W2108683345 cites W1965658167 @default.
• W2108683345 cites W1969156543 @default.
• W2108683345 cites W1970805105 @default.
• W2108683345 cites W1975344770 @default.
• W2108683345 cites W1979495599 @default.
• W2108683345 cites W1990182744 @default.
• W2108683345 cites W1993873975 @default.
• W2108683345 cites W1995340470 @default.
• W2108683345 cites W1995734405 @default.
• W2108683345 cites W1996989437 @default.
• W2108683345 cites W2008771500 @default.
• W2108683345 cites W2009479133 @default.
• W2108683345 cites W2022761976 @default.
• W2108683345 cites W2024771202 @default.
• W2108683345 cites W2031098338 @default.
• W2108683345 cites W2036227669 @default.
• W2108683345 cites W2040920498 @default.
• W2108683345 cites W2042231547 @default.
• W2108683345 cites W2042706359 @default.
• W2108683345 cites W2042971659 @default.
• W2108683345 cites W2043366273 @default.
• W2108683345 cites W2054548024 @default.
• W2108683345 cites W2058353252 @default.
• W2108683345 cites W2069268633 @default.
• W2108683345 cites W2070677232 @default.
• W2108683345 cites W2080364938 @default.
• W2108683345 cites W2080549108 @default.
• W2108683345 cites W2086956756 @default.
• W2108683345 cites W2089075506 @default.
• W2108683345 cites W2096773810 @default.
• W2108683345 cites W2097378006 @default.
• W2108683345 cites W2100488282 @default.
• W2108683345 cites W2100818058 @default.
• W2108683345 cites W2117689856 @default.
• W2108683345 cites W2120108803 @default.
• W2108683345 cites W2126784809 @default.
• W2108683345 cites W2127361161 @default.
• W2108683345 cites W2134127282 @default.
• W2108683345 cites W2138639547 @default.
• W2108683345 cites W2139548473 @default.
• W2108683345 cites W2315987042 @default.
• W2108683345 cites W2418532320 @default.
• W2108683345 cites W2420431878 @default.
• W2108683345 cites W38812705 @default.
• W2108683345 doi "https://doi.org/10.1210/jcem.83.2.4539" @default.
• W2108683345 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9467542" @default.
• W2108683345 hasPublicationYear "1998" @default.
• W2108683345 type Work @default.
• W2108683345 sameAs 2108683345 @default.
• W2108683345 citedByCount "62" @default.
• W2108683345 countsByYear W21086833452012 @default.
• W2108683345 countsByYear W21086833452013 @default.
• W2108683345 countsByYear W21086833452017 @default.
• W2108683345 countsByYear W21086833452018 @default.
• W2108683345 countsByYear W21086833452020 @default.
• W2108683345 countsByYear W21086833452021 @default.
• W2108683345 countsByYear W21086833452022 @default.
• W2108683345 crossrefType "journal-article" @default.
• W2108683345 hasAuthorship W2108683345A5019588231 @default.
• W2108683345 hasAuthorship W2108683345A5020828922 @default.
• W2108683345 hasAuthorship W2108683345A5021824564 @default.
• W2108683345 hasAuthorship W2108683345A5035917425 @default.
• W2108683345 hasAuthorship W2108683345A5036225117 @default.
• W2108683345 hasAuthorship W2108683345A5054386349 @default.
• W2108683345 hasAuthorship W2108683345A5057810981 @default.
• W2108683345 hasAuthorship W2108683345A5063690905 @default.
• W2108683345 hasAuthorship W2108683345A5064098247 @default.
• W2108683345 hasAuthorship W2108683345A5068392916 @default.
• W2108683345 hasAuthorship W2108683345A5081672652 @default.
• W2108683345 hasAuthorship W2108683345A5085391346 @default.
• W2108683345 hasBestOaLocation W21086833451 @default.
• W2108683345 hasConcept C126322002 @default.
• W2108683345 hasConcept C134018914 @default.
• W2108683345 hasConcept C142724271 @default.
• W2108683345 hasConcept C204787440 @default.
• W2108683345 hasConcept C27081682 @default.
• W2108683345 hasConcept C2778024521 @default.
• W2108683345 hasConcept C2779306644 @default.
• W2108683345 hasConcept C2780161494 @default.

• next